Schedule 13G ownership disclosure

BIO-TECHNE CORP COM

COMMON STOCK · CUSIP: 09073M104

Event date: 2025-03-31

Filing-level shares
11,383,607
Percent of class
7.2%
  • T. Rowe Price Associates, Inc.

    Shares: 11,383,607 · Class: 7.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000080255-25-000347
Form type
SCHEDULE 13G/A
Filer
BIO-TECHNE Corp
CIK
CIK 842023
Filed
May 14, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub